Turn Therapeutics Inc.

US$9.48As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TTRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (686.28%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM 95.46%
Mkt cap US$282.4M
ROIC (123.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$10
6.25%
(83.23%)
Hold 12|4|1|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.11
0.12
12.57%
12.37%
9.96%
8.36%
Revenue$M
13.40
14.14
14.17
14.68
4.24%
10.54%
8.21%
10.81%
Peers (US$282.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.970
(0.677)
(0.573)
EBIT/Intx
0.813
0.210
0.230
Own earn%
(86.88)
(213.30)
(139.99)
Sh yield%
33.18
16.37
17.14
Owners
Insiders/Inst%
11.77
29.67
Short interest%
5.74
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
6–9
$1 testx
0.0
Incr. ROIC%
4